What is GV's health score?

As of October 31, 2026, TradeApes rates Visionary Holdings Inc. (GV) 48 out of 100 (Mixed); valuation verdict: Inconclusive. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GV's estimated fair value?

Our methods couldn't reach a reliable fair value for GV yet. This is a model assessment, not a price target or investment recommendation.

Is GV undervalued or overvalued?

Our model currently rates GV as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

📱 Now on iPhone — live scores, valuations & alerts on the go

Download iPhone App

Visionary Holdings Inc. (GV)

Name: TradeApes health score and valuation for Visionary Holdings Inc. (GV)
Creator: TradeApes
License: https://www.tradeapes.com/terms.html

Consumer Cyclical Inconclusive inconclusive mixed

$0.14

Updated: 2026-10-31

As of October 31, 2026, TradeApes rates Visionary Holdings Inc. (GV) 48 out of 100 (Mixed); valuation verdict: Inconclusive.

TradeApes Score

Financial Strength

40 Weak

Operating Trend

50 Mixed

Relative Value

40 Overvalued

Capital Allocation

50 Mixed

Risk Management

80 Strong

Our methods couldn't reach a reliable fair value for GV yet.

Key Findings

What to watch

− Weak liquidity — current assets below current liabilities
− Low FCF yield — below 1%, price implies exceptional future growth

See every signal behind GV's score →

AI-written analysis

The full Visionary Holdings Inc. (GV) analysis

Why the model reads GV as inconclusive, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written

Industry Related Stocks

ATA Creativity Global (AACG) NP Life Sciences Health Industry Group Inc. (ACAT) Afya Ltd (AFYA) Ambow Education Holding Ltd. (AMBO) AMERICAN PUBLIC EDUCATION INC (APEI) ASPEN GROUP, INC. (ASPU)

See all Consumer Cyclical stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.